The persistent and growing global challenge of neurodegenerative diseases, particularly Alzheimer’s disease, has intensified the search for modifiable risk factors…
Read More
Johns Hopkins Researchers Identify Key Protein and Gas Signaling Pathway as Potential Target for Alzheimer’s Disease Treatment
Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the understanding of Alzheimer’s disease, identifying a specific protein…
Read More
Brain Immune System Response Linked to Early Loss of Smell in Alzheimer’s Disease Patients
The decline of the olfactory sense has long been observed as a precursor to the cognitive deterioration associated with Alzheimer’s…
Read More
Boosting one protein helps the brain fight Alzheimer’s
In a significant advancement for neurodegenerative research, scientists at Baylor College of Medicine have identified a biological pathway that enables…
Read More
FDA Approves Auvelity for Alzheimer’s Disease Agitation, Offering a Novel Treatment Option
The U.S. Food and Drug Administration (FDA) has granted approval to Axsome Therapeutics’ Auvelity (dextromethorphan HBr and bupropion HCl) for…
Read More
Real-Time Observation of Metal-Induced Protein Clumping Offers New Pathways for Alzheimer’s Treatment Strategies
In a significant advancement for neurodegenerative research, a team of scientists at Oregon State University, in collaboration with a dedicated…
Read More
Lifelong Cognitive Enrichment Linked to Significant Delays in Alzheimer’s Onset and Cognitive Decline
Engaging in a consistent regimen of mentally stimulating activities throughout the course of one’s life—ranging from childhood literacy to adult…
Read More
Midlife Vitamin D Levels Linked to Lower Alzheimer’s Tau Biomarker; Study Signals Implications for Clinical Labs
A landmark longitudinal study, published on April 1, 2026, in Neurology Open Access, an official journal of the American Academy…
Read More
Loss of Smell in Early Alzheimer’s Linked to Immune System Attacks on Olfactory Nerve Fibers
For decades, the clinical hallmark of Alzheimer’s disease has been the progressive erosion of memory and cognitive function. However, emerging…
Read More
Johns Hopkins Researchers Identify Critical Protein Pathway in Alzheimer’s Disease Linked to Hydrogen Sulfide Production
Researchers at Johns Hopkins Medicine have unveiled a significant breakthrough in the understanding of Alzheimer’s disease, identifying a specific protein…
Read MoreYOU MAY HAVE MISSED
